Concepts (180)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anesthetics | 4 | 2024 | 11 | 2.450 |
Why?
|
| Drug Interactions | 4 | 2024 | 150 | 1.600 |
Why?
|
| Pharmaceutical Preparations | 2 | 2021 | 94 | 1.290 |
Why?
|
| Chronic Disease | 2 | 2021 | 549 | 1.110 |
Why?
|
| Laryngoscopes | 2 | 2016 | 2 | 0.980 |
Why?
|
| Electrocardiography | 3 | 2023 | 185 | 0.960 |
Why?
|
| Herb-Drug Interactions | 1 | 2024 | 5 | 0.850 |
Why?
|
| Plant Preparations | 1 | 2024 | 24 | 0.840 |
Why?
|
| Coronary Artery Disease | 1 | 2023 | 163 | 0.730 |
Why?
|
| Laryngoscopy | 2 | 2016 | 6 | 0.610 |
Why?
|
| Intubation, Intratracheal | 2 | 2016 | 23 | 0.610 |
Why?
|
| Pain Measurement | 5 | 2017 | 183 | 0.520 |
Why?
|
| Video-Assisted Surgery | 1 | 2016 | 4 | 0.490 |
Why?
|
| Fiber Optic Technology | 1 | 2016 | 11 | 0.490 |
Why?
|
| Cervical Vertebrae | 1 | 2016 | 18 | 0.480 |
Why?
|
| Betamethasone | 1 | 2015 | 3 | 0.460 |
Why?
|
| Perioperative Care | 3 | 2024 | 11 | 0.450 |
Why?
|
| Steroids | 1 | 2015 | 45 | 0.450 |
Why?
|
| Postoperative Complications | 3 | 2016 | 263 | 0.450 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2017 | 187 | 0.420 |
Why?
|
| Low Back Pain | 1 | 2015 | 101 | 0.410 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2012 | 5 | 0.380 |
Why?
|
| Anesthesiology | 2 | 2024 | 7 | 0.380 |
Why?
|
| Humans | 29 | 2024 | 43102 | 0.370 |
Why?
|
| Clinical Competence | 2 | 2024 | 156 | 0.340 |
Why?
|
| Internship and Residency | 2 | 2024 | 146 | 0.330 |
Why?
|
| Ambulatory Surgical Procedures | 3 | 2016 | 7 | 0.290 |
Why?
|
| Postoperative Nausea and Vomiting | 3 | 2020 | 3 | 0.280 |
Why?
|
| Adult | 10 | 2023 | 13872 | 0.280 |
Why?
|
| Obesity | 1 | 2016 | 1151 | 0.270 |
Why?
|
| United States | 3 | 2024 | 5205 | 0.260 |
Why?
|
| Anesthetics, Local | 2 | 2017 | 20 | 0.260 |
Why?
|
| Equipment Design | 3 | 2016 | 145 | 0.260 |
Why?
|
| HIV-1 | 1 | 2012 | 755 | 0.250 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2023 | 42 | 0.250 |
Why?
|
| Prospective Studies | 6 | 2017 | 1600 | 0.250 |
Why?
|
| Anesthesia, Conduction | 2 | 2016 | 3 | 0.240 |
Why?
|
| Patient Satisfaction | 4 | 2016 | 165 | 0.230 |
Why?
|
| HIV Infections | 3 | 2016 | 2586 | 0.220 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2016 | 146 | 0.220 |
Why?
|
| Antiretroviral Therapy, Highly Active | 3 | 2016 | 229 | 0.210 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2017 | 587 | 0.200 |
Why?
|
| Phytotherapy | 1 | 2024 | 75 | 0.200 |
Why?
|
| Faculty, Medical | 1 | 2024 | 74 | 0.200 |
Why?
|
| Time Factors | 4 | 2016 | 1857 | 0.200 |
Why?
|
| Aged | 7 | 2017 | 8214 | 0.190 |
Why?
|
| Pneumothorax | 1 | 2022 | 9 | 0.190 |
Why?
|
| Female | 15 | 2024 | 24698 | 0.190 |
Why?
|
| Middle Aged | 11 | 2017 | 12222 | 0.190 |
Why?
|
| Dietary Supplements | 1 | 2024 | 213 | 0.190 |
Why?
|
| Heart | 1 | 2023 | 184 | 0.180 |
Why?
|
| Analgesics, Opioid | 4 | 2016 | 252 | 0.160 |
Why?
|
| Midazolam | 2 | 2016 | 3 | 0.160 |
Why?
|
| Anesthetics, Intravenous | 2 | 2016 | 4 | 0.160 |
Why?
|
| Educational Measurement | 1 | 2020 | 102 | 0.150 |
Why?
|
| Adenosine | 2 | 2017 | 62 | 0.150 |
Why?
|
| Dexamethasone | 2 | 2017 | 55 | 0.150 |
Why?
|
| Male | 14 | 2024 | 23409 | 0.150 |
Why?
|
| Aged, 80 and over | 2 | 2016 | 2853 | 0.150 |
Why?
|
| Anxiety | 2 | 2017 | 874 | 0.150 |
Why?
|
| Anesthesia | 2 | 2016 | 16 | 0.140 |
Why?
|
| Treatment Outcome | 4 | 2015 | 1604 | 0.130 |
Why?
|
| Autonomic Nerve Block | 1 | 2017 | 2 | 0.130 |
Why?
|
| Intercostal Nerves | 1 | 2017 | 2 | 0.130 |
Why?
|
| Analgesia, Epidural | 1 | 2017 | 6 | 0.130 |
Why?
|
| Manifest Anxiety Scale | 1 | 2017 | 3 | 0.130 |
Why?
|
| Preoperative Period | 1 | 2017 | 9 | 0.130 |
Why?
|
| Interleukin-4 | 1 | 2017 | 75 | 0.130 |
Why?
|
| Analgesia | 1 | 2016 | 11 | 0.130 |
Why?
|
| Facial Expression | 1 | 2017 | 25 | 0.130 |
Why?
|
| Preanesthetic Medication | 1 | 2016 | 1 | 0.130 |
Why?
|
| Coronary Stenosis | 1 | 2017 | 37 | 0.130 |
Why?
|
| Propofol | 1 | 2016 | 8 | 0.130 |
Why?
|
| Carbon Dioxide | 1 | 2017 | 86 | 0.130 |
Why?
|
| Hypnotics and Sedatives | 1 | 2016 | 27 | 0.120 |
Why?
|
| Retrospective Studies | 4 | 2016 | 2544 | 0.120 |
Why?
|
| Positron-Emission Tomography | 1 | 2017 | 93 | 0.120 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2016 | 14 | 0.120 |
Why?
|
| Immobilization | 1 | 2016 | 11 | 0.120 |
Why?
|
| Mental Recall | 1 | 2016 | 84 | 0.120 |
Why?
|
| Ritonavir | 1 | 2016 | 15 | 0.120 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2016 | 21 | 0.120 |
Why?
|
| Single-Blind Method | 1 | 2016 | 54 | 0.120 |
Why?
|
| Double-Blind Method | 5 | 2017 | 317 | 0.120 |
Why?
|
| HIV Protease Inhibitors | 1 | 2016 | 24 | 0.120 |
Why?
|
| Bariatric Surgery | 1 | 2016 | 23 | 0.120 |
Why?
|
| Quality Assurance, Health Care | 1 | 2016 | 55 | 0.120 |
Why?
|
| Hemodynamics | 1 | 2016 | 100 | 0.120 |
Why?
|
| Anesthetics, Dissociative | 1 | 2015 | 1 | 0.120 |
Why?
|
| Injections, Epidural | 1 | 2015 | 1 | 0.120 |
Why?
|
| Sternotomy | 1 | 2015 | 2 | 0.120 |
Why?
|
| Heart, Artificial | 1 | 2015 | 11 | 0.110 |
Why?
|
| Ketamine | 1 | 2015 | 13 | 0.110 |
Why?
|
| Arthroplasty | 1 | 2014 | 3 | 0.110 |
Why?
|
| Osteoarthritis, Hip | 1 | 2014 | 6 | 0.110 |
Why?
|
| Emergency Nursing | 1 | 2014 | 6 | 0.110 |
Why?
|
| Myelography | 1 | 2014 | 1 | 0.110 |
Why?
|
| Spinal Puncture | 1 | 2014 | 2 | 0.110 |
Why?
|
| Young Adult | 2 | 2016 | 5080 | 0.110 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2014 | 2 | 0.110 |
Why?
|
| Nursing Staff, Hospital | 1 | 2014 | 21 | 0.110 |
Why?
|
| Spinal Diseases | 1 | 2014 | 24 | 0.110 |
Why?
|
| HIV-Associated Lipodystrophy Syndrome | 1 | 2014 | 31 | 0.110 |
Why?
|
| Hypercapnia | 1 | 2014 | 7 | 0.110 |
Why?
|
| Coronary Circulation | 1 | 2014 | 29 | 0.110 |
Why?
|
| Ventricular Function, Left | 1 | 2014 | 114 | 0.100 |
Why?
|
| Cardiomyopathies | 1 | 2014 | 65 | 0.100 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2014 | 96 | 0.100 |
Why?
|
| Hippocampus | 1 | 2017 | 594 | 0.100 |
Why?
|
| Acupressure | 1 | 2012 | 1 | 0.090 |
Why?
|
| Disposable Equipment | 1 | 2012 | 6 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 1124 | 0.090 |
Why?
|
| Laparoscopy | 1 | 2012 | 59 | 0.090 |
Why?
|
| Inflammation | 1 | 2017 | 758 | 0.090 |
Why?
|
| Opioid-Related Disorders | 1 | 2014 | 195 | 0.090 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2010 | 27 | 0.080 |
Why?
|
| Ibuprofen | 1 | 2010 | 34 | 0.080 |
Why?
|
| Viral Load | 1 | 2012 | 348 | 0.080 |
Why?
|
| Pyrazoles | 1 | 2010 | 103 | 0.080 |
Why?
|
| Qualitative Research | 2 | 2024 | 574 | 0.080 |
Why?
|
| Sulfonamides | 1 | 2010 | 91 | 0.080 |
Why?
|
| Anesthesia Recovery Period | 1 | 2009 | 1 | 0.080 |
Why?
|
| Methyl Ethers | 1 | 2009 | 1 | 0.080 |
Why?
|
| Isoflurane | 1 | 2009 | 3 | 0.080 |
Why?
|
| Anesthesia, Inhalation | 1 | 2009 | 3 | 0.080 |
Why?
|
| Anesthetics, Inhalation | 1 | 2009 | 4 | 0.080 |
Why?
|
| Cough | 1 | 2009 | 20 | 0.080 |
Why?
|
| Activities of Daily Living | 3 | 2020 | 139 | 0.080 |
Why?
|
| Antiemetics | 2 | 2020 | 8 | 0.060 |
Why?
|
| Health Personnel | 2 | 2022 | 277 | 0.060 |
Why?
|
| Vasodilator Agents | 2 | 2017 | 55 | 0.060 |
Why?
|
| Dogs | 2 | 2017 | 204 | 0.060 |
Why?
|
| Adolescent | 1 | 2016 | 6081 | 0.050 |
Why?
|
| Competency-Based Education | 1 | 2024 | 11 | 0.050 |
Why?
|
| Feedback | 1 | 2024 | 56 | 0.050 |
Why?
|
| Education, Medical, Graduate | 1 | 2024 | 61 | 0.050 |
Why?
|
| Age Factors | 2 | 2016 | 1154 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2017 | 1081 | 0.050 |
Why?
|
| Decision Making | 1 | 2024 | 249 | 0.040 |
Why?
|
| Chi-Square Distribution | 2 | 2012 | 236 | 0.040 |
Why?
|
| Aftercare | 1 | 2020 | 22 | 0.040 |
Why?
|
| Checklist | 1 | 2020 | 17 | 0.040 |
Why?
|
| Goals | 1 | 2020 | 34 | 0.040 |
Why?
|
| Los Angeles | 2 | 2012 | 394 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2020 | 128 | 0.040 |
Why?
|
| Exercise Test | 1 | 2017 | 74 | 0.030 |
Why?
|
| Orthopedic Procedures | 1 | 2016 | 10 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 234 | 0.030 |
Why?
|
| Anesthesia, General | 1 | 2016 | 9 | 0.030 |
Why?
|
| Prosthesis Implantation | 1 | 2015 | 16 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 2015 | 53 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 611 | 0.030 |
Why?
|
| Hospitals | 1 | 2016 | 117 | 0.030 |
Why?
|
| Professional Misconduct | 1 | 2014 | 2 | 0.030 |
Why?
|
| Microglia | 1 | 2017 | 208 | 0.030 |
Why?
|
| Spinal Cord Compression | 1 | 2014 | 4 | 0.030 |
Why?
|
| Substance Abuse Detection | 1 | 2014 | 31 | 0.030 |
Why?
|
| Myocardial Contraction | 1 | 2014 | 46 | 0.030 |
Why?
|
| Animals | 3 | 2017 | 16992 | 0.030 |
Why?
|
| Health Care Surveys | 1 | 2014 | 152 | 0.030 |
Why?
|
| Oximetry | 1 | 2014 | 11 | 0.030 |
Why?
|
| Triglycerides | 1 | 2014 | 147 | 0.030 |
Why?
|
| Image Enhancement | 1 | 2014 | 37 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 440 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2014 | 301 | 0.020 |
Why?
|
| Ondansetron | 1 | 2012 | 3 | 0.020 |
Why?
|
| Myocardium | 1 | 2014 | 263 | 0.020 |
Why?
|
| Serotonin Antagonists | 1 | 2012 | 22 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2017 | 1766 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2012 | 173 | 0.020 |
Why?
|
| Aging | 1 | 2017 | 783 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2015 | 666 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2014 | 1285 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 1596 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2016 | 1759 | 0.020 |
Why?
|
| Placebo Effect | 1 | 2010 | 14 | 0.020 |
Why?
|
| Italy | 1 | 2010 | 27 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2010 | 107 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2010 | 260 | 0.020 |
Why?
|
| Risk Factors | 1 | 2014 | 3994 | 0.020 |
Why?
|